VERAX CONSULTORIA
Verax Consultoria is a management consulting firm that aims to assist organizations in achieving continuously improving results. The company is known for its work on highly complex and critical projects for its clientele. Verax Consultoria's approach to M&A processes is unique and meticulous, treating each case individually. The company values independence, allowing for transparency and frankness in its business consulting services.
VERAX CONSULTORIA
Social Links:
Industry:
Consulting Management Consulting Professional Services
Founded:
2002-01-01
Address:
Sรฃo Paulo, Sao Paulo, Brazil
Country:
Brazil
Website Url:
http://www.veraxc.com
Total Employee:
11+
Status:
Active
Contact:
55(11)3266-7000
Email Addresses:
[email protected]
Similar Organizations
Health Care Program Advisors
Health Care Program Advisors is a healthcare management consulting firm that provides analytical and operations improvement services.
HSM Advisory
HSM Advisory is a management consulting firm that helps leaders transform their organizations by collaborating with their employees.
Innovareshoy
Innovareshoy is a management consulting agency that focuses on developing skills to enhance organizations.
Instituto Pieron
Instituto Pieron is a firm that offers consulting services for human resources, managemental, and organizational development of companies.
LX-360
LX-360 is management consulting firm directed at professionalizing the management and the relationship of companies with the market.
Recon Strategy
Recon Strategy is a management consulting firm focused on health care strategy, operations, and change management.
Together Business Consulting
Together Business Consulting is a Management Consulting company that offers business transformation management and professional service.
VBMC Consultores
VBMC Consultores is a business consulting firm, developing and implementing management programs to promote results.
Official Site Inspections
http://www.veraxc.com
- Host name: 187.17.111.98
- IP address: 187.17.111.98
- Location: Brazil
- Latitude: -22.8305
- Longitude: -43.2192
- Timezone: America/Sao_Paulo

More informations about "Verax Consultoria"
About us - Veraxa
At VERAXA Biotech, we strive to establish the premiere drug discovery and development engine for antibody-drug conjugates (ADCs) and novel antibody-based therapy concepts. By wielding a suite of transformative technological โฆSee details»
Our approach - Veraxa
At VERAXA, we are building an R&D organization suited to meet this future demand. A strong history in ADC development. VERAXA has established a strong position in ADC development. โฆSee details»
VERAXA Biotech - Crunchbase Company Profile
Organization. VERAXA Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. VERAXA โฆSee details»
VERAXA Biotech and Voyager Acquisition Corp. Announce
6 days ago VERAXA Biotech AG: Voyager Acquisition Corp. Dr. Christoph Antz CEO Telephone: +49-6221-3521330 Email: [email protected] Mr. Adeel Rouf Chief Executive โฆSee details»
Veraxa Biotech - Org Chart, Teams, Culture & Jobs - The Org
View Veraxa Biotech's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
VERAXA Biotech | The Pharmaletter
5 days ago The transaction values VERAXA at a pre-money equity value of $1.3 billion, with up to $253 million in cash held in trust. The merger is expected to close in the fourth quarter of โฆSee details»
VERAXA - 2025 Company Profile, Funding & Competitors - Tracxn
3 days ago VERAXA is a series B company based in Heidelberg (Germany), founded in 2017 by Christine Köhler, Christoph A. Merten and Edward A. Lemke. It operates as a Developer of โฆSee details»
Veraxa 2025 Company Profile: Valuation, Funding & Investors
Who are Veraxaโs investors? EMBL Enterprise Management Technology Transfer, EMBL Ventures, and Xlife Sciences have invested in Veraxa. Data Transparency. Meet our data โฆSee details»
Veraxa Biotech AG โ Swiss Biotech
Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members, the association works to secure favorable framework โฆSee details»
Veraxa
The VERAXA team is constantly evolving its technology suite to build better and safer medicinesSee details»
VERAXA Biotech GmbH - Drug pipelines, Patents, Clinical trials
With this clinical asset, VERAXA strengthens its internal cancer pipeline of innovative antibodies and antibody-drug conjugates (ADCs). AML, characterized by its prevalence in individuals over the age of 68 and accounting for approximately 1% of all cancer occurrences, has long presented a challenge in the medical community, particularly for those under 45 where it is less common.See details»
VERAXA Biotech GmbH - BIO International Convention | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... VERAXA is an early-stage โฆSee details»
German antibody maker valued at $1.6B in blank-check merger
6 days ago Dive Brief: Veraxa Biotech, a cancer therapy developer backed by Swiss incubator Xlife Sciences, will go public through a combination with a blank-check entity in a deal that will โฆSee details»
Biotech Leaders Voyager And VERAXA Set To Join Forces
6 days ago This merger combines Voyager Acquisition and VERAXA Biotech to pioneer new cancer therapies, marking its Nasdaq debut under 'VERX'. Valued at $1.3 billion, this strategic โฆSee details»
VERAXA Biotech and Voyager Acquisition Corp. Announce โฆ
6 days ago VERAXA Biotech was founded on scientific breakthroughs made at the European Molecular Biology Laboratory ("EMBL"), a world-renowned institution known for pioneering life science research and ...See details»
Verax Solutions Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Verax Solutions Corporation of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
Veraxa Biotech Set to Go Public with $1.6 Billion SPAC Merger: A โฆ
5 days ago Veraxa aims to leverage artificial intelligence to reduce side effects and maximize market impact in cancer treatment. Overview of the SPAC Merger and Financial Implications. In a move set to reshape its future, Veraxa Biotech, a Germany-based startup focused on cutting-edge cancer therapies, is positioned to go public by merging with a special ...See details»
Swiss biotech Veraxa vaults to Nasdaq listing with SPAC deal
6 days ago Zurich-based start-up Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, gaining a listing on the Nasdaq that will give it โฆSee details»
VERAXA Biotech AG and Voyager Acquisition Corp.
6 days ago Summary. On April 23, 2025, VERAXA Biotech AG and Voyager Acquisition Corp., a Cayman Islands exempted company and special purpose acquisition company targeting the โฆSee details»
Voyager Acquisition Corp. and VERAXA Biotech Announce โฆ
6 days ago The combination will result in VERAXA becoming a publicly traded company on Nasdaq under the ticker symbol โVERXโ, with a pre-money equity valuation of $1.3 billion and โฆSee details»